nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—Carboplatin—bone cancer	0.448	0.539	CbGbCtD
Cefaclor—MPO—Cisplatin—bone cancer	0.383	0.461	CbGbCtD
Cefaclor—Blood creatinine increased—Epirubicin—bone cancer	0.000398	0.00236	CcSEcCtD
Cefaclor—Hyponatraemia—Doxorubicin—bone cancer	0.000394	0.00234	CcSEcCtD
Cefaclor—Hyperhidrosis—Cisplatin—bone cancer	0.000393	0.00233	CcSEcCtD
Cefaclor—Asthma—Methotrexate—bone cancer	0.000392	0.00233	CcSEcCtD
Cefaclor—Eosinophilia—Methotrexate—bone cancer	0.000388	0.00231	CcSEcCtD
Cefaclor—Anorexia—Cisplatin—bone cancer	0.000387	0.0023	CcSEcCtD
Cefaclor—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000382	0.00227	CcSEcCtD
Cefaclor—Hypotension—Cisplatin—bone cancer	0.00038	0.00226	CcSEcCtD
Cefaclor—Face oedema—Doxorubicin—bone cancer	0.000379	0.00225	CcSEcCtD
Cefaclor—Gastritis—Epirubicin—bone cancer	0.000376	0.00223	CcSEcCtD
Cefaclor—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000374	0.00222	CcSEcCtD
Cefaclor—Pancytopenia—Methotrexate—bone cancer	0.000372	0.00221	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00037	0.0022	CcSEcCtD
Cefaclor—Blood creatinine increased—Doxorubicin—bone cancer	0.000368	0.00219	CcSEcCtD
Cefaclor—Asthma—Epirubicin—bone cancer	0.000367	0.00218	CcSEcCtD
Cefaclor—Influenza—Epirubicin—bone cancer	0.000367	0.00218	CcSEcCtD
Cefaclor—Dysuria—Methotrexate—bone cancer	0.000367	0.00218	CcSEcCtD
Cefaclor—Neutropenia—Methotrexate—bone cancer	0.000367	0.00218	CcSEcCtD
Cefaclor—Paraesthesia—Cisplatin—bone cancer	0.000365	0.00217	CcSEcCtD
Cefaclor—Eosinophilia—Epirubicin—bone cancer	0.000363	0.00216	CcSEcCtD
Cefaclor—Dyspnoea—Cisplatin—bone cancer	0.000362	0.00215	CcSEcCtD
Cefaclor—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000354	0.0021	CcSEcCtD
Cefaclor—Decreased appetite—Cisplatin—bone cancer	0.000353	0.0021	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Cisplatin—bone cancer	0.000351	0.00208	CcSEcCtD
Cefaclor—Infestation NOS—Methotrexate—bone cancer	0.00035	0.00208	CcSEcCtD
Cefaclor—Infestation—Methotrexate—bone cancer	0.00035	0.00208	CcSEcCtD
Cefaclor—Pancytopenia—Epirubicin—bone cancer	0.000348	0.00207	CcSEcCtD
Cefaclor—Gastritis—Doxorubicin—bone cancer	0.000348	0.00207	CcSEcCtD
Cefaclor—Pain—Cisplatin—bone cancer	0.000347	0.00206	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000347	0.00206	CcSEcCtD
Cefaclor—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000346	0.00206	CcSEcCtD
Cefaclor—Dysuria—Epirubicin—bone cancer	0.000343	0.00204	CcSEcCtD
Cefaclor—Neutropenia—Epirubicin—bone cancer	0.000343	0.00204	CcSEcCtD
Cefaclor—Conjunctivitis—Methotrexate—bone cancer	0.00034	0.00202	CcSEcCtD
Cefaclor—Asthma—Doxorubicin—bone cancer	0.00034	0.00202	CcSEcCtD
Cefaclor—Influenza—Doxorubicin—bone cancer	0.00034	0.00202	CcSEcCtD
Cefaclor—Eosinophilia—Doxorubicin—bone cancer	0.000336	0.002	CcSEcCtD
Cefaclor—Sweating—Methotrexate—bone cancer	0.000335	0.00199	CcSEcCtD
Cefaclor—Feeling abnormal—Cisplatin—bone cancer	0.000335	0.00199	CcSEcCtD
Cefaclor—Haematuria—Methotrexate—bone cancer	0.000333	0.00198	CcSEcCtD
Cefaclor—Hepatobiliary disease—Methotrexate—bone cancer	0.000331	0.00196	CcSEcCtD
Cefaclor—Epistaxis—Methotrexate—bone cancer	0.00033	0.00196	CcSEcCtD
Cefaclor—Infestation—Epirubicin—bone cancer	0.000327	0.00194	CcSEcCtD
Cefaclor—Infestation NOS—Epirubicin—bone cancer	0.000327	0.00194	CcSEcCtD
Cefaclor—Agranulocytosis—Methotrexate—bone cancer	0.000326	0.00194	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000324	0.00193	CcSEcCtD
Cefaclor—Pancytopenia—Doxorubicin—bone cancer	0.000322	0.00192	CcSEcCtD
Cefaclor—Body temperature increased—Cisplatin—bone cancer	0.000321	0.00191	CcSEcCtD
Cefaclor—Conjunctivitis—Epirubicin—bone cancer	0.000318	0.00189	CcSEcCtD
Cefaclor—Dysuria—Doxorubicin—bone cancer	0.000317	0.00189	CcSEcCtD
Cefaclor—Neutropenia—Doxorubicin—bone cancer	0.000317	0.00189	CcSEcCtD
Cefaclor—Haemoglobin—Methotrexate—bone cancer	0.000315	0.00187	CcSEcCtD
Cefaclor—Haemorrhage—Methotrexate—bone cancer	0.000314	0.00186	CcSEcCtD
Cefaclor—Hepatitis—Methotrexate—bone cancer	0.000314	0.00186	CcSEcCtD
Cefaclor—Sweating—Epirubicin—bone cancer	0.000314	0.00186	CcSEcCtD
Cefaclor—Haematuria—Epirubicin—bone cancer	0.000312	0.00185	CcSEcCtD
Cefaclor—Urinary tract disorder—Methotrexate—bone cancer	0.00031	0.00184	CcSEcCtD
Cefaclor—Hepatobiliary disease—Epirubicin—bone cancer	0.000309	0.00184	CcSEcCtD
Cefaclor—Epistaxis—Epirubicin—bone cancer	0.000309	0.00183	CcSEcCtD
Cefaclor—Urethral disorder—Methotrexate—bone cancer	0.000308	0.00183	CcSEcCtD
Cefaclor—Sinusitis—Epirubicin—bone cancer	0.000307	0.00182	CcSEcCtD
Cefaclor—Agranulocytosis—Epirubicin—bone cancer	0.000305	0.00181	CcSEcCtD
Cefaclor—Infestation NOS—Doxorubicin—bone cancer	0.000303	0.0018	CcSEcCtD
Cefaclor—Infestation—Doxorubicin—bone cancer	0.000303	0.0018	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.0003	0.00178	CcSEcCtD
Cefaclor—Hypersensitivity—Cisplatin—bone cancer	0.000299	0.00178	CcSEcCtD
Cefaclor—Erythema multiforme—Methotrexate—bone cancer	0.000297	0.00176	CcSEcCtD
Cefaclor—Haemoglobin—Epirubicin—bone cancer	0.000295	0.00175	CcSEcCtD
Cefaclor—Rhinitis—Epirubicin—bone cancer	0.000294	0.00175	CcSEcCtD
Cefaclor—Conjunctivitis—Doxorubicin—bone cancer	0.000294	0.00175	CcSEcCtD
Cefaclor—Haemorrhage—Epirubicin—bone cancer	0.000294	0.00175	CcSEcCtD
Cefaclor—Hepatitis—Epirubicin—bone cancer	0.000294	0.00175	CcSEcCtD
Cefaclor—Asthenia—Cisplatin—bone cancer	0.000292	0.00173	CcSEcCtD
Cefaclor—Sweating—Doxorubicin—bone cancer	0.00029	0.00172	CcSEcCtD
Cefaclor—Urinary tract disorder—Epirubicin—bone cancer	0.00029	0.00172	CcSEcCtD
Cefaclor—Oedema peripheral—Epirubicin—bone cancer	0.000289	0.00172	CcSEcCtD
Cefaclor—Haematuria—Doxorubicin—bone cancer	0.000289	0.00171	CcSEcCtD
Cefaclor—Urethral disorder—Epirubicin—bone cancer	0.000288	0.00171	CcSEcCtD
Cefaclor—Hepatobiliary disease—Doxorubicin—bone cancer	0.000286	0.0017	CcSEcCtD
Cefaclor—Epistaxis—Doxorubicin—bone cancer	0.000286	0.0017	CcSEcCtD
Cefaclor—Sinusitis—Doxorubicin—bone cancer	0.000284	0.00169	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—bone cancer	0.000283	0.00168	CcSEcCtD
Cefaclor—Agranulocytosis—Doxorubicin—bone cancer	0.000283	0.00168	CcSEcCtD
Cefaclor—Chills—Methotrexate—bone cancer	0.000282	0.00167	CcSEcCtD
Cefaclor—Diarrhoea—Cisplatin—bone cancer	0.000278	0.00165	CcSEcCtD
Cefaclor—Erythema multiforme—Epirubicin—bone cancer	0.000278	0.00165	CcSEcCtD
Cefaclor—Haemoglobin—Doxorubicin—bone cancer	0.000273	0.00162	CcSEcCtD
Cefaclor—Rhinitis—Doxorubicin—bone cancer	0.000272	0.00162	CcSEcCtD
Cefaclor—Hepatitis—Doxorubicin—bone cancer	0.000272	0.00161	CcSEcCtD
Cefaclor—Haemorrhage—Doxorubicin—bone cancer	0.000272	0.00161	CcSEcCtD
Cefaclor—Urinary tract disorder—Doxorubicin—bone cancer	0.000268	0.00159	CcSEcCtD
Cefaclor—Oedema peripheral—Doxorubicin—bone cancer	0.000268	0.00159	CcSEcCtD
Cefaclor—Urethral disorder—Doxorubicin—bone cancer	0.000266	0.00158	CcSEcCtD
Cefaclor—Immune system disorder—Epirubicin—bone cancer	0.000265	0.00158	CcSEcCtD
Cefaclor—Back pain—Methotrexate—bone cancer	0.000264	0.00157	CcSEcCtD
Cefaclor—Chills—Epirubicin—bone cancer	0.000264	0.00157	CcSEcCtD
Cefaclor—Vomiting—Cisplatin—bone cancer	0.000258	0.00153	CcSEcCtD
Cefaclor—Erythema multiforme—Doxorubicin—bone cancer	0.000257	0.00153	CcSEcCtD
Cefaclor—Rash—Cisplatin—bone cancer	0.000256	0.00152	CcSEcCtD
Cefaclor—Dermatitis—Cisplatin—bone cancer	0.000256	0.00152	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—bone cancer	0.000253	0.00151	CcSEcCtD
Cefaclor—Flatulence—Epirubicin—bone cancer	0.000252	0.0015	CcSEcCtD
Cefaclor—Tension—Epirubicin—bone cancer	0.000251	0.00149	CcSEcCtD
Cefaclor—Nervousness—Epirubicin—bone cancer	0.000248	0.00148	CcSEcCtD
Cefaclor—Back pain—Epirubicin—bone cancer	0.000247	0.00147	CcSEcCtD
Cefaclor—Malaise—Methotrexate—bone cancer	0.000246	0.00146	CcSEcCtD
Cefaclor—Immune system disorder—Doxorubicin—bone cancer	0.000245	0.00146	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—bone cancer	0.000245	0.00146	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—bone cancer	0.000245	0.00145	CcSEcCtD
Cefaclor—Chills—Doxorubicin—bone cancer	0.000244	0.00145	CcSEcCtD
Cefaclor—Nausea—Cisplatin—bone cancer	0.000241	0.00143	CcSEcCtD
Cefaclor—Cough—Methotrexate—bone cancer	0.000238	0.00142	CcSEcCtD
Cefaclor—Ill-defined disorder—Epirubicin—bone cancer	0.000237	0.00141	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—bone cancer	0.000237	0.00141	CcSEcCtD
Cefaclor—Agitation—Epirubicin—bone cancer	0.000235	0.0014	CcSEcCtD
Cefaclor—Flatulence—Doxorubicin—bone cancer	0.000233	0.00139	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—bone cancer	0.000233	0.00138	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—bone cancer	0.000233	0.00138	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—bone cancer	0.000233	0.00138	CcSEcCtD
Cefaclor—Tension—Doxorubicin—bone cancer	0.000232	0.00138	CcSEcCtD
Cefaclor—Malaise—Epirubicin—bone cancer	0.000231	0.00137	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—bone cancer	0.00023	0.00137	CcSEcCtD
Cefaclor—Nervousness—Doxorubicin—bone cancer	0.00023	0.00137	CcSEcCtD
Cefaclor—Vertigo—Epirubicin—bone cancer	0.00023	0.00136	CcSEcCtD
Cefaclor—Syncope—Epirubicin—bone cancer	0.000229	0.00136	CcSEcCtD
Cefaclor—Leukopenia—Epirubicin—bone cancer	0.000229	0.00136	CcSEcCtD
Cefaclor—Back pain—Doxorubicin—bone cancer	0.000229	0.00136	CcSEcCtD
Cefaclor—Palpitations—Epirubicin—bone cancer	0.000226	0.00134	CcSEcCtD
Cefaclor—Confusional state—Methotrexate—bone cancer	0.000225	0.00134	CcSEcCtD
Cefaclor—Loss of consciousness—Epirubicin—bone cancer	0.000225	0.00134	CcSEcCtD
Cefaclor—Cough—Epirubicin—bone cancer	0.000223	0.00133	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—bone cancer	0.000223	0.00132	CcSEcCtD
Cefaclor—Convulsion—Epirubicin—bone cancer	0.000222	0.00132	CcSEcCtD
Cefaclor—Ill-defined disorder—Doxorubicin—bone cancer	0.00022	0.0013	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—bone cancer	0.000219	0.0013	CcSEcCtD
Cefaclor—Thrombocytopenia—Methotrexate—bone cancer	0.000218	0.0013	CcSEcCtD
Cefaclor—Myalgia—Epirubicin—bone cancer	0.000218	0.00129	CcSEcCtD
Cefaclor—Chest pain—Epirubicin—bone cancer	0.000218	0.00129	CcSEcCtD
Cefaclor—Arthralgia—Epirubicin—bone cancer	0.000218	0.00129	CcSEcCtD
Cefaclor—Agitation—Doxorubicin—bone cancer	0.000217	0.00129	CcSEcCtD
Cefaclor—Anxiety—Epirubicin—bone cancer	0.000217	0.00129	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—bone cancer	0.000216	0.00128	CcSEcCtD
Cefaclor—Discomfort—Epirubicin—bone cancer	0.000215	0.00128	CcSEcCtD
Cefaclor—Malaise—Doxorubicin—bone cancer	0.000213	0.00127	CcSEcCtD
Cefaclor—Vertigo—Doxorubicin—bone cancer	0.000213	0.00126	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—bone cancer	0.000213	0.00126	CcSEcCtD
Cefaclor—Syncope—Doxorubicin—bone cancer	0.000212	0.00126	CcSEcCtD
Cefaclor—Leukopenia—Doxorubicin—bone cancer	0.000212	0.00126	CcSEcCtD
Cefaclor—Confusional state—Epirubicin—bone cancer	0.00021	0.00125	CcSEcCtD
Cefaclor—Palpitations—Doxorubicin—bone cancer	0.000209	0.00124	CcSEcCtD
Cefaclor—Oedema—Epirubicin—bone cancer	0.000209	0.00124	CcSEcCtD
Cefaclor—Anaphylactic shock—Epirubicin—bone cancer	0.000209	0.00124	CcSEcCtD
Cefaclor—Hypotension—Methotrexate—bone cancer	0.000208	0.00124	CcSEcCtD
Cefaclor—Loss of consciousness—Doxorubicin—bone cancer	0.000208	0.00124	CcSEcCtD
Cefaclor—Cough—Doxorubicin—bone cancer	0.000206	0.00123	CcSEcCtD
Cefaclor—Shock—Epirubicin—bone cancer	0.000205	0.00122	CcSEcCtD
Cefaclor—Convulsion—Doxorubicin—bone cancer	0.000205	0.00122	CcSEcCtD
Cefaclor—Nervous system disorder—Epirubicin—bone cancer	0.000205	0.00122	CcSEcCtD
Cefaclor—Thrombocytopenia—Epirubicin—bone cancer	0.000204	0.00121	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000203	0.00121	CcSEcCtD
Cefaclor—Hyperhidrosis—Epirubicin—bone cancer	0.000202	0.0012	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—bone cancer	0.000202	0.0012	CcSEcCtD
Cefaclor—Arthralgia—Doxorubicin—bone cancer	0.000201	0.0012	CcSEcCtD
Cefaclor—Chest pain—Doxorubicin—bone cancer	0.000201	0.0012	CcSEcCtD
Cefaclor—Myalgia—Doxorubicin—bone cancer	0.000201	0.0012	CcSEcCtD
Cefaclor—Anxiety—Doxorubicin—bone cancer	0.000201	0.00119	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—bone cancer	0.0002	0.00119	CcSEcCtD
Cefaclor—Discomfort—Doxorubicin—bone cancer	0.000199	0.00118	CcSEcCtD
Cefaclor—Anorexia—Epirubicin—bone cancer	0.000199	0.00118	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—bone cancer	0.000199	0.00118	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—bone cancer	0.000198	0.00118	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—bone cancer	0.000196	0.00117	CcSEcCtD
Cefaclor—Hypotension—Epirubicin—bone cancer	0.000195	0.00116	CcSEcCtD
Cefaclor—Confusional state—Doxorubicin—bone cancer	0.000195	0.00116	CcSEcCtD
Cefaclor—Decreased appetite—Methotrexate—bone cancer	0.000194	0.00115	CcSEcCtD
Cefaclor—Anaphylactic shock—Doxorubicin—bone cancer	0.000193	0.00115	CcSEcCtD
Cefaclor—Oedema—Doxorubicin—bone cancer	0.000193	0.00115	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—bone cancer	0.000193	0.00114	CcSEcCtD
Cefaclor—Pain—Methotrexate—bone cancer	0.000191	0.00113	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00019	0.00113	CcSEcCtD
Cefaclor—Shock—Doxorubicin—bone cancer	0.00019	0.00113	CcSEcCtD
Cefaclor—Nervous system disorder—Doxorubicin—bone cancer	0.000189	0.00112	CcSEcCtD
Cefaclor—Thrombocytopenia—Doxorubicin—bone cancer	0.000189	0.00112	CcSEcCtD
Cefaclor—Insomnia—Epirubicin—bone cancer	0.000189	0.00112	CcSEcCtD
Cefaclor—Paraesthesia—Epirubicin—bone cancer	0.000187	0.00111	CcSEcCtD
Cefaclor—Hyperhidrosis—Doxorubicin—bone cancer	0.000187	0.00111	CcSEcCtD
Cefaclor—Dyspnoea—Epirubicin—bone cancer	0.000186	0.00111	CcSEcCtD
Cefaclor—Somnolence—Epirubicin—bone cancer	0.000186	0.0011	CcSEcCtD
Cefaclor—Anorexia—Doxorubicin—bone cancer	0.000184	0.00109	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—bone cancer	0.000184	0.00109	CcSEcCtD
Cefaclor—Dyspepsia—Epirubicin—bone cancer	0.000184	0.00109	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—bone cancer	0.000182	0.00108	CcSEcCtD
Cefaclor—Decreased appetite—Epirubicin—bone cancer	0.000181	0.00108	CcSEcCtD
Cefaclor—Hypotension—Doxorubicin—bone cancer	0.00018	0.00107	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Epirubicin—bone cancer	0.00018	0.00107	CcSEcCtD
Cefaclor—Pain—Epirubicin—bone cancer	0.000178	0.00106	CcSEcCtD
Cefaclor—Constipation—Epirubicin—bone cancer	0.000178	0.00106	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—bone cancer	0.000177	0.00105	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—bone cancer	0.000176	0.00105	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—bone cancer	0.000176	0.00105	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000176	0.00105	CcSEcCtD
Cefaclor—Insomnia—Doxorubicin—bone cancer	0.000175	0.00104	CcSEcCtD
Cefaclor—Paraesthesia—Doxorubicin—bone cancer	0.000173	0.00103	CcSEcCtD
Cefaclor—Dyspnoea—Doxorubicin—bone cancer	0.000172	0.00102	CcSEcCtD
Cefaclor—Feeling abnormal—Epirubicin—bone cancer	0.000172	0.00102	CcSEcCtD
Cefaclor—Somnolence—Doxorubicin—bone cancer	0.000172	0.00102	CcSEcCtD
Cefaclor—Gastrointestinal pain—Epirubicin—bone cancer	0.000171	0.00101	CcSEcCtD
Cefaclor—Dyspepsia—Doxorubicin—bone cancer	0.00017	0.00101	CcSEcCtD
Cefaclor—Decreased appetite—Doxorubicin—bone cancer	0.000168	0.000997	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000167	0.00099	CcSEcCtD
Cefaclor—Urticaria—Epirubicin—bone cancer	0.000166	0.000985	CcSEcCtD
Cefaclor—Pain—Doxorubicin—bone cancer	0.000165	0.000981	CcSEcCtD
Cefaclor—Constipation—Doxorubicin—bone cancer	0.000165	0.000981	CcSEcCtD
Cefaclor—Abdominal pain—Epirubicin—bone cancer	0.000165	0.00098	CcSEcCtD
Cefaclor—Body temperature increased—Epirubicin—bone cancer	0.000165	0.00098	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—bone cancer	0.000164	0.000976	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—bone cancer	0.00016	0.000951	CcSEcCtD
Cefaclor—Feeling abnormal—Doxorubicin—bone cancer	0.000159	0.000945	CcSEcCtD
Cefaclor—Gastrointestinal pain—Doxorubicin—bone cancer	0.000158	0.000938	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—bone cancer	0.000158	0.000937	CcSEcCtD
Cefaclor—Hypersensitivity—Epirubicin—bone cancer	0.000154	0.000913	CcSEcCtD
Cefaclor—Urticaria—Doxorubicin—bone cancer	0.000153	0.000911	CcSEcCtD
Cefaclor—Abdominal pain—Doxorubicin—bone cancer	0.000153	0.000907	CcSEcCtD
Cefaclor—Body temperature increased—Doxorubicin—bone cancer	0.000153	0.000907	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—bone cancer	0.000153	0.000906	CcSEcCtD
Cefaclor—Asthenia—Epirubicin—bone cancer	0.00015	0.00089	CcSEcCtD
Cefaclor—Pruritus—Epirubicin—bone cancer	0.000148	0.000877	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—bone cancer	0.000147	0.000876	CcSEcCtD
Cefaclor—Diarrhoea—Epirubicin—bone cancer	0.000143	0.000848	CcSEcCtD
Cefaclor—Hypersensitivity—Doxorubicin—bone cancer	0.000142	0.000845	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—bone cancer	0.000142	0.000842	CcSEcCtD
Cefaclor—Rash—Methotrexate—bone cancer	0.000141	0.000835	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—bone cancer	0.00014	0.000835	CcSEcCtD
Cefaclor—Headache—Methotrexate—bone cancer	0.00014	0.00083	CcSEcCtD
Cefaclor—Asthenia—Doxorubicin—bone cancer	0.000139	0.000823	CcSEcCtD
Cefaclor—Dizziness—Epirubicin—bone cancer	0.000138	0.00082	CcSEcCtD
Cefaclor—Pruritus—Doxorubicin—bone cancer	0.000137	0.000812	CcSEcCtD
Cefaclor—Vomiting—Epirubicin—bone cancer	0.000133	0.000788	CcSEcCtD
Cefaclor—Nausea—Methotrexate—bone cancer	0.000132	0.000787	CcSEcCtD
Cefaclor—Diarrhoea—Doxorubicin—bone cancer	0.000132	0.000785	CcSEcCtD
Cefaclor—Rash—Epirubicin—bone cancer	0.000132	0.000782	CcSEcCtD
Cefaclor—Dermatitis—Epirubicin—bone cancer	0.000131	0.000781	CcSEcCtD
Cefaclor—Headache—Epirubicin—bone cancer	0.000131	0.000777	CcSEcCtD
Cefaclor—Dizziness—Doxorubicin—bone cancer	0.000128	0.000759	CcSEcCtD
Cefaclor—Nausea—Epirubicin—bone cancer	0.000124	0.000736	CcSEcCtD
Cefaclor—Vomiting—Doxorubicin—bone cancer	0.000123	0.000729	CcSEcCtD
Cefaclor—Rash—Doxorubicin—bone cancer	0.000122	0.000723	CcSEcCtD
Cefaclor—Dermatitis—Doxorubicin—bone cancer	0.000122	0.000723	CcSEcCtD
Cefaclor—Headache—Doxorubicin—bone cancer	0.000121	0.000719	CcSEcCtD
Cefaclor—Nausea—Doxorubicin—bone cancer	0.000115	0.000681	CcSEcCtD
